Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
of 5

PrevOnco ' Analysis and Market Forecasts from 2014 to 2020

PrevOnco ' Analysis and Market Forecasts from 2014 to 2020SummaryGlobalData's pharmaceuticals report, 'PrevOnco ' Analysis and Market Forecasts from 2014 to 2020' provides PrevOnco sales estimates for the US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Liver Cancer market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Scope- Therapy area profile including patient population for the US and EU5- Analysis and review of PrevOnco including sales data- Qualitative and quantitative assessment of market space- Analysis of the trends, drivers and restraints shaping and defining the markets- In-depth analysis of PrevOnco including efficacy, safety, pricing and other details which influence its sales potential- Detailed sales forecast for 2014-2020 for PrevOnco in the US and EU5- Reasons to buy- Understand and capitalize by identifying products that are most likely to ensure a robust return- Stay ahead of competition by understanding the changing competitive landscape- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential- Make more informed business decisions from insightful and in-depth analysis of the drug's performance - Examine the historical sales performance of a drug in seven major markets- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Published on: Mar 4, 2016
Source: www.slideshare.net


Transcripts - PrevOnco ' Analysis and Market Forecasts from 2014 to 2020

  • 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!PrevOnco Analysis and Market Forecasts from 2014 to 2020Published on October 2011 Report SummaryPrevOnco Analysis and Market Forecasts from 2014 to 2020SummaryGlobalDatas pharmaceuticals report, PrevOnco Analysis and Market Forecasts from 2014 to 2020 provides PrevOnco salesestimates for the US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitivelandscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on LiverCancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary andsecondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both fromcompany and industry-specific third party sources, put together with in-house analysis, by GlobalDatas team of industry experts.Scope- Therapy area profile including patient population for the US and EU5- Analysis and review of PrevOnco including sales data- Qualitative and quantitative assessment of market space- Analysis of the trends, drivers and restraints shaping and defining the markets- In-depth analysis of PrevOnco including efficacy, safety, pricing and other details which influence its sales potential- Detailed sales forecast for 2014-2020 for PrevOnco in the US and EU5-Reasons to buy- Understand and capitalize by identifying products that are most likely to ensure a robust return- Stay ahead of competition by understanding the changing competitive landscape- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential- Make more informed business decisions from insightful and in-depth analysis of the drugs performance- Examine the historical sales performance of a drug in seven major markets- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets Table of Content1 Table of contents1 Table of contents 21.1 List of Tables 31.2 List of Figures 32 Introduction 42.1 Liver Cancer Market 4PrevOnco Analysis and Market Forecasts from 2014 to 2020 (From Slideshare) Page 1/5
  • 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!2.2 Epidemiology 42.3 Etiology 52.3.1 Hepatitis B Infection 52.3.2 Hepatitis C Infection 52.3.3 Alcohol 52.3.4 Aflatoxin B1 62.3.5 Hemochromatosis 62.3.6 Diabetes and Obesity 62.3.7 Cirrhosis 62.4 GlobalData Report Guidance 63 Liver Cancer : Market Characterization 73.1 Liver Cancer Market 73.2 Liver Cancer Market Forecasts and CAGR 73.3 Drivers for the Liver Cancer Market 73.3.1 High Incidence 83.3.2 High Mortality 93.3.3 Large Unmet Need 94 TumorNodeMetastases (TNM) Classification of Liver Cancer 105 PrevOnco 115.1 Introduction 115.2 Mechanism of Action 115.3 Indications of PrevOnco 115.4 Factors Affecting Sales of PrevOnco 115.4.1 Both First Line and Second Line Treatments 115.4.2 NexACT NexMeds Drug Delivery Technology 115.4.3 Absence in Japan Market 125.4.4 Orphan Drug Status 125.5 Intensity of Competition 125.6 Sales Forecast 125.6.1 Target Patient Pool of PrevOnco 125.6.2 Dosing 135.6.3 Market Penetration 135.6.4 Annual Cost of Therapy 145.6.5 Sales Projections of PrevOnco 156 Liver Cancer Market: Appendix 236.1 Market Definitions 236.2 List of Abberiviations 236.3 Research Methodology 236.3.1 Coverage 236.3.2 Secondary Research 236.3.3 Forecasting 246.3.4 Number of Patients Approved to take the Drug 246.3.5 Net Penetration of Drug 256.3.6 Net Annual Dosing 256.3.7 Annual Cost of Therapy 256.3.8 Primary Research 256.3.9 Expert Panels 266.4 Drug Sales Estimates Model 26PrevOnco Analysis and Market Forecasts from 2014 to 2020 (From Slideshare) Page 2/5
  • 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!6.5 Contact Us 276.6 Disclaimer 276.7 Sources 271.1 List of TablesTable 1: Liver Cancer, Incidences and Mortality, 20082030 4Table 2: Annual Cost of Therapy 14Table 3: PrevOnco, Liver Cancer, Global, Sales Forecasts ($m), 20142020 15Table 4: PrevOnco, Liver Cancer, The US, Sales Forecasts ($m), 20142020 16Table 5: PrevOnco, Liver Cancer, The UK, Sales Forecasts ($m), 20152020 17Table 6: PrevOnco, Liver Cancer, France, Sales Forecasts ($m), 20152020 18Table 7: PrevOnco, Liver Cancer, Germany, Sales Forecasts ($m), 20152020 19Table 8: PrevOnco, Liver Cancer, Italy, Sales Forecasts ($m), 20152020 20Table 9: PrevOnco, Liver Cancer, Spain, Sales Forecasts ($m), 20152020 21Table 10: Drug Risk Benefit Score of Drug X 261.2 List of FiguresFigure 1: Fatality = [(% Distribution of Incidence) (% Distribution of Mortality)] of Most Common Cancers 5Figure 2: Liver Cancer, Global, Market Size Forecast ($m), 20102020 7Figure 3: Liver Cancer, Worldwide, Incidence (in millions), 20082030 8Figure 4: Oncology, Worldwide, Incidence (in millions), 20082030 8Figure 5: Liver Cancer, Worldwide, Mortality (in millions), 20082030 9Figure 6: Classification of Liver Cancer 10Figure 7: Drug Model Diagram of PrevOnco 13Figure 8: PrevOnco, Liver Cancer, Global, Sales Forecasts ($m), 20142020 15Figure 9: PrevOnco, Liver Cancer, The US, Sales Forecasts ($m), 20142020 16Figure 10: PrevOnco, Liver Cancer, The UK, Sales Forecasts ($m), 20152020 17Figure 11: PrevOnco, Liver Cancer, France, Sales Forecasts ($m), 20152020 18Figure 12: PrevOnco, Liver Cancer, Germany, Sales Forecasts ($m), 20152020 19Figure 13: PrevOnco, Liver Cancer, Italy, Sales Forecasts ($m), 20152020 20Figure 14: PrevOnco, Liver Cancer, Spain, Sales Forecasts ($m), 20152020 21Figure 15: PrevOnco, Liver Cancer, Global, Sales Distribution by Country (%), 2020 22Figure 16: Drug Model Diagram 24Figure 17: Patients Approved for the Drug 25PrevOnco Analysis and Market Forecasts from 2014 to 2020 (From Slideshare) Page 3/5
  • 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. PrevOnco Analysis and Market Forecasts from 2014 to 2020 Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 000.00 Quantity: _____ Site License--USD 4 000.00 Quantity: _____ Corporate License--USD 6 000.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________PrevOnco Analysis and Market Forecasts from 2014 to 2020 (From Slideshare) Page 4/5
  • 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93PrevOnco Analysis and Market Forecasts from 2014 to 2020 (From Slideshare) Page 5/5

Related Documents